Skip to main content
RNST
NYSE Finance

Renasant Details $140M Commercial Bank & Trust Deal: 75% Stock, ~4% EPS Accretive

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Positive
Importance info
7
Price
$40.19
Mkt Cap
$3.674B
52W Low
$33.04
52W High
$44.54
52W Position info
22% above low
Off High info
9.8% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

RNST sits 22% above its 52-week low of $33.04 on elevated volume (2.2× avg).

Summary

Renasant's Q3 call transcript puts numbers on its $140 million all-stock-and-cash purchase of Commercial Bank & Trust: ~4% EPS accretive, 1.5% dilutive to tangible book, CET1 near 11% at close, targeted to close in Q1 2027.


Key Events · M&A and Partnerships · RNST

  • Deal Terms Quantified

    The Commercial Holding Company acquisition is valued at approximately $140 million, comprised of roughly 75% stock and 25% cash.

  • Accretion and Tangible Book Impact

    Management expects the deal to be approximately 4% accretive to EPS and 1.5% dilutive to tangible book value per share, with an earnback of just under two years.

  • Capital Ratios Hold at Close

    Modest diminution to capital ratios is expected, with CET1 at approximately 11% at close.

  • Q1 2027 Close Targeted

    The deal is expected to close sometime in the first quarter of 2027, subject to the S-4 registration statement, regulatory approvals and Commercial shareholder approval.


Analysis · RNST · Finance

The first hard numbers on the Commercial Holding Company merger announced the day before come through this Rule 425, which carries the transcript of Renasant's Q3 earnings call. Valued at roughly $140 million, the deal is paid about 75% in stock and 25% in cash, and management expects it to add about 4% to EPS while costing 1.5% of tangible book value per share, earning that back in just under two years. At close, CET1 stays around 11%, so the capital base absorbs the deal without a raise. Existing holders get diluted by the stock component, but the acquired franchise brings a low-cost core deposit base and over $1 billion in wealth/trust assets under management, which is the strategic reason for doing it. Closing is targeted for Q1 2027, subject to the S-4 registration statement, regulatory approvals and Commercial shareholder vote.

How filings like this one have moved

In the 30 days to Oct 28, 2026, 30.7% of the 1698 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RNST was trading at $40.19 on NYSE in the Finance sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $33.04 to $44.54. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RNST - Latest Insights

RNST
Oct 27, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $41.58
Real-time Price: $40.19 info
Change: -$1.39 (-3%) info
Market Cap: $3.674B info
RNST
Oct 27, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.58
Real-time Price: $40.19 info
Change: -$1.39 (-3%) info
Market Cap: $3.674B info
RNST
Oct 27, 2026, 4:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $41.58
Real-time Price: $40.19 info
Change: -$1.39 (-3%) info
Market Cap: $3.674B info
RNST
Oct 27, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $41.58
Real-time Price: $40.19 info
Change: -$1.39 (-3%) info
Market Cap: $3.674B info
RNST
Aug 06, 2026, 3:59 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $43.37
Real-time Price: $40.19 info
Change: -$3.18 (-7%) info
Market Cap: $3.674B info